In a comprehensive report released by J.P. Morgan Asset Management, Chairman of Market and Investment Strategy Michael Cembalest forecasts a surprising turn of events in the upcoming presidential race. The report, unveiled on Sunday, January 7, 2024, delves into a myriad of topics, including the state of the US economy, market trends, and global risks, with a notable prediction that President Joe Biden may withdraw from the race between Super Tuesday and the November election due to health apprehensions.
Cembalest’s annual outlook report encompasses his “top ten surprises for 2024,” offering insights into various aspects of the economic and geopolitical landscape. Among these surprises, he anticipates the stability of the US dollar, potential victories for the Department of Justice and the Federal Trade Commission in a major antitrust case, and the unexpected possibility of President Biden stepping down.
Should Biden decide to withdraw, Cembalest envisions the Democratic National Committee nominating a replacement candidate, introducing an unexpected twist to the electoral landscape.
The report further explores diverse areas such as the potential backlash against driverless cars, the rise in broadly syndicated loan (BSL) losses surpassing private credit losses, and potential challenges in Argentine dollarization.
Cembalest’s forecast extends beyond domestic issues, anticipating a continued Russian invasion of Ukraine without a ceasefire in 2024. Despite storm clouds on the horizon, he foresees positive outcomes for stocks of US regional banks.
One of the report’s crucial concerns lies in the possibility of major US cities facing electricity and/or natural gas outages. Cembalest attributes this risk to the retirement of dispatchable power generation (nuclear, coal, gas) and insufficient investment in pipelines, gas storage, and winterization, highlighting potential vulnerabilities in the nation’s energy infrastructure.
The report also touches on advancements in medical research, with Cembalest predicting the completion of work on an inhaled COVID vaccine designed to sharply reduce transmission, aligning with global efforts to combat the ongoing pandemic.
Cembalest attributes President Biden’s current low approval rating to a unique set of circumstances, despite achieving around 10% job creation since his inauguration. Factors such as the timing of his inauguration coinciding with the rollout of COVID-19 vaccines and the reopening of the US economy have impacted his approval. Additionally, Cembalest suggests that Biden’s health could be a contributing factor to his approval challenges, referencing statements from former White House physician Ronnie Jackson in 2021.
While intriguing, it is crucial to approach these predictions with caution, acknowledging that unforeseen events and dynamic political developments can significantly influence the accuracy of such forecasts.
